SF3A3 Promotes Hepatocellular Carcinoma Progression and Regulates Jagged 2–Notch 1 Signaling
Molecular Carcinogenesis · 15.11.2026
DOI: 10.1002/mc.70204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 15.11.2026. Verfasst von Jing Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, C…. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Splicing factor 3a subunit 3 (SF3A3) has been reported to be dysregulated in various cancers. Previous studies have suggested its prognostic value in hepatocellular carcinoma (HCC), but the specific effect and molecular mechanisms remain to be further explored. Therefore, this study aims to investigate the role of SF3A3 in HCC pathogenesis. SF3A3 expression was compared between HCC and normal tissues using public databases and immunohistochemistry, and its clinical significance was evaluated by clinicopathological, ROC, and Kaplan–Meier analyses. Differential expression and enrichment analyses explored potential biological functions. In vitro assays assessed the effects of SF3A3 knockdown on HCC cell proliferation, migration, and invasion. RNA sequencing, molecular validation, and rescue experiments investigated the underlying mechanism, while a nude mouse xenograft model evaluated its role in vivo. SF3A3 was significantly upregulated in HCC and was associated with adverse clinicopathological features. SF3A3 expression showed discriminatory ability between HCC and normal liver tissues in retrospective transcriptomic cohorts and was associated with poor survival. Functional enrichment analyses linked SF3A3 to cell cycle regulation and DNA replication, while SF3A3 knockdown suppressed HCC cell proliferation, migration, and invasion in vitro. Transcriptomic profiling further identified Notch signaling as a potential downstream pathway, and this association was supported by rescue experiments. In conclusion, SF3A3 promotes tumor progression and is associated with regulation of Jagged 2–Notch 1 signaling. These findings provide preliminary insight into the molecular mechanisms underlying SF3A3‐mediated HCC progression and support further investigation of its potential clinical and therapeutic relevance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China.
- Department of General, Visceral & Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany.
- Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China.
ORCID-Profile: Jing Yang, Guangwen Zhou
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, J., Liu, L., Zhang, Y., & Zhou, G. (2026). SF3A3 Promotes Hepatocellular Carcinoma Progression and Regulates Jagged 2–Notch 1 Signaling. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70204
Vancouver
Yang J, Liu L, Zhang Y, Zhou G. SF3A3 Promotes Hepatocellular Carcinoma Progression and Regulates Jagged 2–Notch 1 Signaling. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70204
BibTeX
@article{Yang2026,
author = {Yang, Jing and Liu, Luyang and Zhang, Yan and Zhou, Guangwen},
title = {SF3A3 Promotes Hepatocellular Carcinoma Progression and Regulates Jagged 2–Notch 1 Signaling},
journal = {Molecular Carcinogenesis},
year = {2026},
doi = {10.1002/mc.70204}
}
EUVIMED